L
Lygos
Lygos is providing biotechnology solutions for today's renewable chemical challenges
About Lygos
Lygos, Inc. operates as a vertically integrated provider of safe and sustainable specialty ingredients. The company leverages advanced biological and chemical tools to convert low-cost sugars into high-value products. Lygos primarily serves industries seeking bio-based alternatives to traditional chemical compounds, including the pharmaceutical, agricultural, and industrial sectors. The company’s business model revolves around the commercial-scale fermentation of bio-based cannabinoids and organic acids, such as CBG, CBC, CBD, CBDA, and CBDV, which are used in various applications from health supplements to industrial processes. By optimizing strain performance and increasing operational efficiencies, Lygos ensures the production of highly pure, consistent, and natural ingredients. Revenue is generated through the sale of these specialty ingredients to businesses looking for sustainable and economically advantageous alternatives.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2010
- Headquarters
- Emeryville, United States
- Employees
- 27
- Open positions
- None listed
- Dealroom signal
- 60.2/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Synthetic Biology, Spinout, Sustainable Development Goals, Biotech and Pharma, Fermentation, Climate Tech, YC W16, DT and LS
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2c
- Investment activity
- 1 company, latest Apr 2022
- Capital deployed
- —
- Preferred round
- MERGER
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| MERGER✓Other financing | Apr 2022 | $0 | — | Flexible Solutions International | ↗ |
| SERIES BEquity / VC | Sep 2019 | $5M | $20M | Undisclosed | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Lygos is 1.3K monthly website visits, down 56.7% over the last three months. Lygos's team declined 69% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
US Department of Energy
US National Science Foundation
Y Combinator
Series A9 investors entered at this stage
OS Fund
IA Ventures
First Round Capital
FundersClub
Brainchild
Vast Ventures
Catapult VC
Fifty Years
LG Technology Ventures
Other known investors4 additional known investors
Flexible Solutions International
University of California, Berkeley
10x
Small Business Innovation Research
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Lygos on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Lygos’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.